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Supplemental Information 
Methods 
Cell Culture 
Cells were cultured as described by Griffiths et al.12  In brief, a >95% pure population 
of CD34+ haemopoietic stem cells (HSC) was isolated from human blood donor 
mononuclear cells or from thawed cryopreserved cord blood units by magnetic bead 
separation according to manufacturer’s instructions (Miltenyi Biotec Ltd, Bisley UK). 
Allowing for differences in enucleation and leucofiltration rates, estimated starting 
material of 1-2x105 CD34+ cells from adult or cord should be adequate to yield 2x109 
leucofiltered cRBC at the end of culture, sufficient to inject 10 mice. CD34+ cells 
were seeded into tissue culture flasks at a density of 2x105 cells/ml using a base 
medium consisting of Iscove’s modified Dulbecco’s medium (IMDM, Source 
BioScience, Nottingham UK) containing 3% (v/v) AB Serum (Sigma-Aldrich, Poole 
UK), 2mg/ml HSA (Irvine Scientific, Newtownmountkennedy, Ireland), 10µg/ml 
Insulin (Sigma-Aldrich), 3U/ml heparin (Sigma-Aldrich), 500µg/ml transferrin (R&D 
Systems, Abingdon UK) and 3U/ml Epo (Roche, Welwyn Garden City, UK).  In the 
first stage (days 0-10) this was supplemented with 10ng/ml stem cell factor (SCF, 
Medsafe, Sweden) and 1ng/ml IL-3 (R&D Systems, Abingdon UK) and in the second 
stage (days 11-13) with 10ng/ml SCF.  In the final stage to day 21, base medium 
only was used.  
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Statistical Analyses 
Two-way analysis of variance (ANOVA) was used to compare results in liposome 
depleted and untreated mice.  Post-tests were performed to compare results at each 
time-point.  P-values for these comparisons were adjusted to take into account the 
multiple comparisons performed using the Holm-Sidak method.  These analyses 
were undertaken using GraphPad Prism software, Version 6 for Windows 
(GraphPad Software, San Diego, CA). 
 
The proportion of human cells surviving at each time point in blood samples from 
NSG mice was calculated, taking the value 10 minutes after inoculation as 100%.  
Where observed cell survival reached 50%, a log-quadratic spline function was fitted 
to the data over time for each mouse and the human cell half-life was estimated from 
this.  Results were categorized by source (cord cRBC, adult cRBC and adult RBC) 
and experimental unit.  All mice within an experimental unit received blood from the 
same donor.  ANOVA was used to compare the proportion of human cells surviving 
at each time-point and to compare human cell half-life, by blood source.  Random 
effects were included to allow for correlation between repeated measurements over 
time and between results for blood from the same donor.  Separate ANOVAs were 
performed on experiments where adult cRBC, 5-day old and 26-day old adult red 
cells originated from the same donor.  Blood source and age were combined into 
one factor and the random donor effect was omitted, since there was no variation at 
this level.  Post-tests were performed to compare results for each blood source at 
each time-point.  P-values for these comparisons were adjusted to take into account 
the multiple comparisons performed using the Tukey method.  Mean values were 
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least-squares estimates, based on the analysis of variance model, as described; 
95% confidence intervals (C.I.) are also stated.  These analyses were undertaken 
using SAS/STAT software, Version 9 of the SAS System for Windows (SAS Institute 
Inc., Cary, NC). 
Kupzig	et	al	
Supplemental Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
Supplemental Figure 1 Phenotypic maturation of transfused cells  
Adult cRBC were inoculated into the lateral tail vein of macrophage depleted NSG 
mice and blood samples were collected at 10 minutes, 24, 48 and 72 hours.  
Maturation of the human cells was evaluated by measuring the expression of CD235 
and CD71 in murine blood by flow cytometry. (A) Isotype control of a 1:100 dilution of 
adult leucofiltered cRBC in a murine peripheral blood aspirate.  Cells were initially 
gated on forward and side scatter (i), Glycophorin A positive cells were gated (ii) and 
the proportion of CD71+ cells within this population is shown (iii).  CD235-FITC and 
CD71-RPE dual labelled cells, gated on forward and side scatter, are also shown 
(iv).  Corresponding plots from adult cRBC after 10 minutes (B) and after 24 hours 
(C) are shown.  The proportion of CD71 positive cells detected decreased over time.  
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Supplemental Figure 2 In vivo maturation of cRBC and adult RBC in NSG 
 mice 
cRBC or adult blood cells were inoculated into the lateral tail vein of macrophage 
depleted NSG mice.  Peripheral blood samples were taken from the opposite lateral 
tail vein at 10 minutes, 24, 48 and 72 hours.  Human cells were detected by 
measuring expression of glycophorin A (CD235) in murine blood by flow cytometry.  
Cells were co-stained with thiazole orange and the amount of residual nucleic acid 
remaining was expressed as a percentage of the total number of GPA-positive 
human cells. 
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Supplemental Figure 3 Proportion of human cells in the mouse circulation 
cRBC or adult blood cells were inoculated into the lateral tail vein of macrophage 
depleted NSG mice.  Human cells were detected by measuring the expression of 
CD235 in murine blood by flow cytometry. (A) Proportion of human cord blood cRBC, 
adult cRBC and donor RBC surviving in the mouse circulation.  Data represent 
mean±SE of 4 independent experiments for cord blood cultured reticulocytes, 8 
independent experiments for the adult cultured reticulocytes and 5 independent 
experiments for standard donor cells.  Mice in each independent experiment were 
injected with cells from the same donor. (B) Direct paired comparison of cRBC and 
RBC from the same donor surviving in the mouse circulation. The proportion of adult 
cRBC and day 5 and day 26 donor cells detected in the murine circulation are 
shown.  Data represent mean±SE. 
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Supplemental Figure 4 Comparison of in vivo survival of fresh and stored 
 donor RBC 
Adult red blood cells from the same donor were inoculated into NSG mice at 8 days 
(n=6) and 29 days (n=3) following donation.  Peripheral blood aspirates were taken 
over a 72 hour period and CD235+ cells were measured by flow cytometry.  (A) 
Proportion of human cells surviving in mouse circulation.  The proportion of human 
cells were normalized with the levels detected 10 minutes after inoculation set to 
100%.  The levels of human cells detected in NSG were significantly higher in 
recipients of day 8 cells over the entire time course of the experiment (P=0.004, T 
Test).  Data represent mean±SE. (B)  Half-life of human cells in transfused NSG 
mice, by source.  Two-tailed T test confirmed longer half-lives of day 8 donor RBC 
(67.9±10 hours) than day 29 RBC (24.6+5 hours, P=0.01).  Each point represents an 
individual mouse, lines represent mean±SE. 
 
